Trovagene (TROV) Misses Q2 EPS by 3c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/10/2026

1. HUM
2. SPCX
3. ALHC
4. T
5. PEP
6. SPY
7. CVS
8. UNH
9. ZETA
10. DAL

Go back to Trovagene (TROV) Misses Q2 EPS by 3c

Cantor Fitzgerald Upgrades TrovaGene (TROV) to Buy

August 8, 2016 7:28 AM EDT

Cantor Fitzgerald upgraded TrovaGene (NASDAQ: TROV) from Hold to Buy with a price target of $7.00 (from $5.00).

For an analyst ratings summary and ratings history on TrovaGene click here. For more ratings news on TrovaGene click here.

Shares of TrovaGene closed at $5.20 yesterday.

... More

Piper Jaffray Remains Sidelined on Trovagene (TROV) Following 2Q Miss

August 5, 2016 10:04 AM EDT

Piper Jaffray maintained a Neutral rating on TrovaGene (NASDAQ: TROV), and cut the price target to $4.00 (from $5.00), following the company's 2Q earnings report. Trovagene reported revenue of $104K, below the Street' ~$270K. Total revenue consisted of royalty revenue of $48K as well as test revenue of $56K.

Analyst William... More